Jane Street
AKBA icon

Jane Street’s Akebia Therapeutics AKBA Stock Holding History

Jane Street’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$183K Buy
131,900
+18,100
+16% +$24.9K ﹤0.01% 10234
2025
Q4 		$183K Buy
113,800
+72,900
+178% +$153K ﹤0.01% 9800
2025
Q3 		$112K Buy
40,900
+8,800
+27% +$29.3K ﹤0.01% 10080
2025
Q2 		$117K Buy
32,100
+20,400
+174% +$56.1K ﹤0.01% 8883
2025
Q1 		$22.5K Buy
+11,700
New +$23.9K ﹤0.01% 9138
2024
Q3 		– Sell
-17,400
Closed -$17.7K – 9504
2024
Q2 		$17.7K Sell
17,400
-51,300
-75% -$63.4K ﹤0.01% 9051
2024
Q1 		$126K Buy
+68,700
New +$110K ﹤0.01% 8440
2023
Q1 		– Sell
-27,700
Closed -$16K – 8934
2022
Q4 		$16K Sell
27,700
-3,600
-12% -$1.13K ﹤0.01% 8656
2022
Q3 		$10K Sell
31,300
-16,000
-34% -$6.28K ﹤0.01% 9344
2022
Q2 		$17K Sell
47,300
-116,800
-71% -$49K ﹤0.01% 9201
2022
Q1 		$118K Buy
164,100
+145,500
+782% +$311K ﹤0.01% 9373
2021
Q4 		$42K Sell
18,600
-67,600
-78% -$184K ﹤0.01% 9589
2021
Q3 		$248K Sell
86,200
-32,300
-27% -$92.2K ﹤0.01% 8522
2021
Q2 		$449K Buy
118,500
+37,800
+47% +$127K ﹤0.01% 7440
2021
Q1 		$273K Buy
80,700
+16,600
+26% +$59.8K ﹤0.01% 7825
2020
Q4 		$179K Sell
64,100
-37,800
-37% -$110K ﹤0.01% 7002
2020
Q3 		$256K Buy
+101,900
New +$894K ﹤0.01% 6103

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jane Street's AKBA Position: Q1 2026 in Review

Jane Street increased its Akebia Therapeutics (AKBA) stake by 111% in Q1 2026, buying an estimated $1.05M and bringing the position to 1,456,674 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #5074.

Jane Street first reported a position in AKBA in Q2 2014 and has held it in 33 quarters since. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Jane Street held 1,456,674 shares of Akebia Therapeutics worth $2.02M as of Q1 2026.
  • Jane Street bought 765,090 Akebia Therapeutics shares in Q1 2026, an estimated $1.05M.
  • Akebia Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5074 holding.
  • Jane Street first reported a position in Akebia Therapeutics in Q2 2014 and has held it in 33 quarters since.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.